Rafael Holdings, Inc. Class B (RFL): Price and Financial Metrics
Rafael Holdings, Inc. Class B (RFL)
Today's Latest Price: $16.09 USD
Updated Sep 25 7:00pm
Add RFL to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
RFL Stock Summary
- The ratio of debt to operating expenses for Rafael Holdings Inc is higher than it is for about merely 0.34% of US stocks.
- With a price/sales ratio of 50.18, Rafael Holdings Inc has a higher such ratio than 95.87% of stocks in our set.
- With a year-over-year growth in debt of -100%, Rafael Holdings Inc's debt growth rate surpasses only 0% of about US stocks.
- Stocks that are quantitatively similar to RFL, based on their financial statements, market capitalization, and price volatility, are ROG, OFIX, SILK, CUB, and ISDR.
- RFL's SEC filings can be seen here. And to visit Rafael Holdings Inc's official web site, go to www.rafaelholdings.com.
RFL Stock Price Chart Technical Analysis Charts
RFL Price/Volume Stats
| Current price | $16.09 | 52-week high | $23.76 |
| Prev. close | $16.00 | 52-week low | $9.40 |
| Day low | $15.54 | Volume | 8,720 |
| Day high | $16.60 | Avg. volume | 32,954 |
| 50-day MA | $16.33 | Dividend yield | N/A |
| 200-day MA | $16.02 | Market Cap | 254.50M |
Rafael Holdings, Inc. Class B (RFL) Company Bio
Rafael Holdings, Inc., through its subsidiary, manufactures metabolic oncology drugs to treat cancer. The company also owns and operates real estate properties. The company was incorporated in 2017 and is based in Newark, New Jersey. Rafael Holdings, Inc. operates as a subsidiary of IDT Corporation
Loading social stream, please wait...